Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

LumiraDx SARS-CoV-2 Ag Test

Microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens

Supplier:  LumiraDx L016000109048

Catalog No. 22-181-001


Due to product restrictions, please to purchase or view availability for this product.

Explore available promotions
This item is not returnable. View return policy

Description

Description

  • Features:
    • High-sensitivity, microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens from patients suspected of COVID-19 with
    • Results in 12 minutes
    • Uses nasal samples to detect nucleocapsid protein antigen with 97.6 % positive agreement to an EUA approved RT-PCR method within the first 12 days of symptom onset
    • For use with the LumiraDx instrument
  • Includes:
    • 48 LumiraDx test strips
    • 48 extraction buffer vials
    • 48 dropper lids
    • LumiraDx SARS-CoV-2 Ag test quick reference instructions
  • Notes:
    • Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high or waived complexity tests
    • Authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
    • Authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens
    • USA only- test is authorized for duration of declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner
Specifications

Specifications

Available separately
SARS-CoV-2 Nucleocapsid Protein Antigen
Microfluidic Immunofluorescence
48 Test Strips/Pk.
Waived
Rapid Test
LumiraDx Instrument
12 min.
Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

Authorized under EUA for use by authorized labs, test has not been FDA cleared or approved